TOULOUSE, FRANCE — The management of patients over the age of 75 years with diabetes is discussed in a crucial chapter in the latest position statement from the Francophone Diabetes Society (SFD). The ...

Younger patients benefit from stricter HbA1c goals, whereas elderly care focuses on symptom control. Glycemic targets should gradually adjust with aging to match changing health and life expectancy.

A recent study provides evidence that in people without diabetes, six risk groups for cardiometabolic complications previously identified in middle-aged people can also be identified in older people.

In a recent systematic review and meta-analysis published in the journal Nutrients, researchers from Italy updated a systematic review and meta-analysis to examine whether low serum vitamin D ...

In recent years, the medical community has been reevaluating traditional approaches to managing type 2 diabetes. A groundbreaking study has shed new light on the potential of low-carbohydrate diets to ...

A startling and worrisome new study conducted at the University of Haifa has found that people who are diagnosed with type-2 diabetes – especially women – face a 50% percent higher risk of developing ...

People who have type 2 diabetes have an increased amount of sugar in their blood, also called blood glucose. Increased blood sugar happens when your body’s insulin doesn’t work as well as it should.

The move broadens treatment choices for pediatric patients aged 10 years and older whose diabetes remains uncontrolled with ...

A recent study found that six cardiometabolic risk groups previously identified in middle-aged individuals can also be applied to older adults without diabetes. Using data from the KORA F4/FF4 study ...

Jardiance (empagliflozin) is a medicine for type 2 diabetes approved by the FDA in 2014. It is approved to help lower blood sugar levels in adults and children with type 2 diabetes and to lower the ...